A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT02076009 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

569

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Daratumumab
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Janssen Research & Development, LLC